Cost Effectiveness of Lacosamide in the Adjunctive Treatment of Patients with Refractory Focal Epilepsy in Belgium

被引：0
作者：
Steven Simoens
Liesbet De Naeyer
Peter Dedeken
机构：
[1] Katholieke Universiteit Leuven,Research Centre for Pharmaceutical Care and Pharmacoeconomics
[2] UCB Pharma,undefined
来源：
CNS Drugs | 2012年 / 26卷
关键词：
Seizure Frequency; Lacosamide; Pivotal Trial; Seizure Freedom; Seizure Reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives: Lacosamide is an anti-epileptic drug, indicated as adjunctive therapy for patients with focal seizures with or without secondary generalization. This study aims to assess the cost effectiveness of standard antiepileptic drug therapy plus lacosamide 300 mg/day compared with standard therapy alone from the perspective of the Belgian healthcare payer.
引用
收藏
页码：337 / 350
页数：13
相关论文
共 58 条
  • [1] Fisher RS(2005)Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) Epilepsia 46 470-2
  • [2] van Emde Boas W(2010)Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009 Epilepsia 51 676-85
  • [3] Blume W(2002)Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures Epilepsia 43 1402-9
  • [4] Berg AT(2007)Mortality in epilepsy Epilepsy Behav 10 363-76
  • [5] Berkovic SF(2011)Cost of disorders of the brain in Europe 2010 Eur Neuropsychopharmacol 21 718-79
  • [6] Brodie MJ(1997)A cost-effectiveness analysis of anterior temporal lobectomy for intractable temporal lobe epilepsy J Neurosurg 87 20-8
  • [7] Kotsopoulos IA(1997)Cost-effectiveness of anterotemporal lobectomy in medically intractable complex partial epilepsy Epilepsia 38 154-63
  • [8] van Merode T(2003)Lifetime cost-utility analysis of patients with refractory epilepsy treated with adjunctive topiramate therapy: cost-effectiveness in refractory epilepsy Clin Drug Investig 23 225-32
  • [9] Kessels FG(1998)Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis Eur J Clin Pharmacol 53 421-7
  • [10] Hitiris N(2005)Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation Health Technol Assess 9 1-186
123456